Suppr超能文献

[儿童血管炎的治疗]

[Therapy of vasculitis in children].

作者信息

Lietti D, Cantone P, Grasso E

机构信息

Divisione Pediatrica, Ospedale S. Anna, USSL 11, Como, Italia.

出版信息

Pediatr Med Chir. 1989 Mar-Apr;11 Suppl 1:63-72.

PMID:2682548
Abstract

Therapy of vasculitis syndromes varies considerably according to different forms and gravity. Mild cases often heal spontaneously. In other cases, when the causal factors are known, the removal of the offending antigen or the treatment of an underlying primary disease are sufficient to obtain remission. In the vasculitis syndromes, in which the causal factors are unknown, therapy is based on various associations of nonsteroidal antiinflammatory drugs, antiplatelet drugs, anticoagulants, corticosteroids and cytotoxic drugs, depending on the type, extention and gravity of disease. In most severe systemic necrotizing vasculitis, therapy with corticosteroids and cytotoxic drugs must be protracted for months, with inevitable side-effects, particularly severe in children. Pulse therapy with intravenous bolus of high doses of methylprednisolone seems to offer a new valid therapeutic approach, but is still under investigation. Plasmapheresis may be successful in acute and grave forms. High dose intravenous gammaglobulin therapy is indicated in the prevention of coronary involvement of Kawasaki disease. In this review these problems and therapeutic regimes suggested by different Authors are discussed, with particular attention to their application in childhood.

摘要

血管炎综合征的治疗因不同的类型和严重程度而有很大差异。轻症病例往往可自愈。在其他情况下,当已知病因时,去除致病抗原或治疗潜在的原发性疾病就足以实现缓解。在病因不明的血管炎综合征中,治疗基于非甾体抗炎药、抗血小板药物、抗凝剂、皮质类固醇和细胞毒性药物的各种联合使用,具体取决于疾病的类型、范围和严重程度。在大多数严重的系统性坏死性血管炎中,使用皮质类固醇和细胞毒性药物的治疗必须持续数月,且不可避免地会有副作用,在儿童中尤为严重。大剂量静脉注射甲基泼尼松龙进行冲击治疗似乎提供了一种新的有效治疗方法,但仍在研究中。血浆置换在急性和严重形式中可能有效。大剂量静脉注射丙种球蛋白疗法适用于预防川崎病的冠状动脉受累。在这篇综述中,将讨论不同作者提出的这些问题和治疗方案,尤其关注它们在儿童中的应用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验